We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
- Authors
Iwasa, Satoru; Morizane, Chigusa; Okusaka, Takuji; Ueno, Hideki; Ikeda, Masafumi; Kondo, Shunsuke; Tanaka, Tsutomu; Nakachi, Kohei; Mitsunaga, Shuichi; Kojima, Yasushi; Hagihara, Atsushi; Hiraoka, Nobuyoshi
- Abstract
The combination chemotherapy consisting of cisplatin and etoposide, one of the standard regimens for small cell lung cancer, has been widely used to treat extrapulmonary poorly differentiated neuroendocrine carcinomas. However, there were no prior reports limited to the hepatobiliary tract and pancreas as the primary sites.
- Publication
Japanese journal of clinical oncology, 2010, Vol 40, Issue 4, p313
- ISSN
1465-3621
- Publication type
Journal Article
- DOI
10.1093/jjco/hyp173